首页> 美国卫生研究院文献>Annals of Vascular Diseases >Is Conventional Open Repair for Abdominal Aortic Aneurysm Feasible in Nonagenarians?
【2h】

Is Conventional Open Repair for Abdominal Aortic Aneurysm Feasible in Nonagenarians?

机译:在非流产者中进行常规的腹主动脉瘤开放修补术可行吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Although endovascular repair for abdominal aortic aneurysm has been found to be beneficial in very elderly patients, some patients have contraindications to this procedure. For nonagenarians, the results of open repair remain unclear. The purpose of this study was to compare the outcomes of open vs. endovascular repair for abdominal aortic aneurysm in nonagenarian patients.>Methods and Results: Fourteen patients undergoing open surgical repair and 24 undergoing endovascular repair for abdominal aortic aneurysm were evaluated. There was no significant difference in early mortality between the open and endovascular groups (0% vs. 4.1%, p=0.16). The open repair group required much longer hospital stays (26.4 vs. 10.6 days, respectively, p=0.003). Finally, 12 patients (86%) undergoing open repair vs. 21 (88%) undergoing endovascular repair returned home (p=0.49). During a mean follow-up period of 23.4±23.5 months, cumulative estimated 1- and 3-year survival rates were 90.0% and 48.0%, respectively in the open repair group and 90.6% and 54.9%, respectively in the endovascular repair group (p=0.51).>Conclusion: Although endovascular repair for abdominal aortic aneurysm was superior in terms of recovery, the results of conventional open repair were acceptable even in nonagenarian patients. Open repair remains an alternative for patients with contraindications to endovascular repair.
机译:>背景:尽管已经发现对老年主动脉血管内修复对腹主动脉瘤是有益的,但有些患者对此方法有禁忌症。对于非老人,开放维修的结果仍不清楚。 >方法和结果:14例行开腹手术的患者和24例行腹主动脉瘤的患者行血管内修复。被评估。开放组和血管内组之间的早期死亡率无显着差异(0%vs. 4.1%,p = 0.16)。开放维修组需要更长的住院时间(分别为26.4天和10.6天,p = 0.003)。最终,有12例患者(86%)接受了开放式修复,而21例(88%)接受了血管内修复。在平均23.4±23.5个月的随访期间,开放修复组的1年和3年累计估计生存率分别为90.0%和48.0%,血管内修复组的分别为90.6%和54.9%( p = 0.51)。>结论:尽管腹主动脉瘤的腔内修复在恢复方面优越,但常规开放性修复的结果即使在非生殖器患者中也可以接受。对于有血管内修复禁忌症的患者,开放式修复仍是另一种选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号